Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 2203)

Brno, Brno-mesto 656 53

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Renal Cell

Studies at this site

• A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011) — Running, not enrolling